165 related articles for article (PubMed ID: 3283760)
1. Ongoing trials in bladder cancer conducted by the EORTC Genito-Urinary Tract Cancer Cooperative Group.
De Pauw M
Prog Clin Biol Res; 1988; 260():215-23. PubMed ID: 3283760
[No Abstract] [Full Text] [Related]
2. Current status of bladder cancer protocols in the EORTC Genito-Urinary Group.
Denis L; Pavone-Macaluso M; De Pauw M
Prog Clin Biol Res; 1984; 162B():429-39. PubMed ID: 6390450
[TBL] [Abstract][Full Text] [Related]
3. Perspectives for progress in the treatment of superficial bladder cancer. The need for multi-institutional studies and the possible role of the EORTC Genito-Urinary Group.
Pavone-Macaluso M; Serrette V
Prog Clin Biol Res; 1989; 310():357-60. PubMed ID: 2672022
[No Abstract] [Full Text] [Related]
4. Adjuvant chemotherapy of bladder cancer.
Freiha FS; Torti FM
Prog Clin Biol Res; 1988; 260():545-9. PubMed ID: 3129738
[No Abstract] [Full Text] [Related]
5. A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
Pawinski A; Sylvester R; Bouffioux C; Kurth KH; Parmar M; Bijnens L
Acta Urol Belg; 1996 May; 64(2):27. PubMed ID: 8701803
[No Abstract] [Full Text] [Related]
6. Carcinoma in situ of the bladder.
Herr HW
Semin Urol; 1983 Feb; 1(1):15-22. PubMed ID: 6679095
[No Abstract] [Full Text] [Related]
7. [BCG immunotherapy in the treatment of superficial bladder tumors].
Samodai L; Drinóczy M; Kolozsy Z; Mohácsi L; Dauda G; Porkoláb Z
Orv Hetil; 1986 Oct; 127(40):2441-6. PubMed ID: 3537907
[No Abstract] [Full Text] [Related]
8. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
Prout GR; Kopp J
Prog Clin Biol Res; 1984; 162B():397-427. PubMed ID: 6438644
[No Abstract] [Full Text] [Related]
9. Hemotherapy--oncological checkmate or surgical aid?
Smith PH
Prog Clin Biol Res; 1988; 260():613-20. PubMed ID: 3283771
[No Abstract] [Full Text] [Related]
10. Neoadjuvant chemotherapy in bladder cancer.
Yagoda A
Urology; 1988 Feb; 31(2 Suppl):9-12. PubMed ID: 3278484
[No Abstract] [Full Text] [Related]
11. Bladder cancer: clinical practice.
Rabinowits G; Laber DA
J Ky Med Assoc; 2009 Apr; 107(4):129-33. PubMed ID: 19419018
[No Abstract] [Full Text] [Related]
12. BCG therapy of superficial bladder tumors.
Herr HW
Prog Clin Biol Res; 1989; 303():369-74. PubMed ID: 2674999
[No Abstract] [Full Text] [Related]
13. Overview of bladder cancer trials in the European Organization for Research and Treatment.
de Wit R;
Cancer; 2003 Apr; 97(8 Suppl):2120-6. PubMed ID: 12673705
[TBL] [Abstract][Full Text] [Related]
14. [Active studies on bladder carcinoma in the year 2004].
Rexer H
Urologe A; 2004 Mar; 43(3):318-20. PubMed ID: 15045194
[No Abstract] [Full Text] [Related]
15. Intravesical therapy for superficial bladder cancer.
Malkowicz SB
Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
[TBL] [Abstract][Full Text] [Related]
16. Management of flat carcinoma in situ of the bladder.
Whitmore WF
Prog Clin Biol Res; 1984; 162B():219-24. PubMed ID: 6504897
[No Abstract] [Full Text] [Related]
17. Overview of advanced urothelial cancer trials of the Eastern Cooperative Oncology Group.
Dreicer R; Roth B; Wilding G;
Cancer; 2003 Apr; 97(8 Suppl):2109-14. PubMed ID: 12673703
[TBL] [Abstract][Full Text] [Related]
18. BCG in carcinoma in situ and superficial bladder tumors.
Lamm DL
Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069
[No Abstract] [Full Text] [Related]
19. Chemotherapy for metastatic bladder cancer; the EORTC experience.
Stoter G
Prog Clin Biol Res; 1988; 260():471-9. PubMed ID: 3283767
[No Abstract] [Full Text] [Related]
20. [In situ carcinoma of the bladder].
González Martín M; Chantada Abal V; Lancina Martín JA; Forteza Vila J; Lamas Meilán AC; Yebra Pimentel MT
Arch Esp Urol; 1985; 38(2):125-30. PubMed ID: 4026393
[No Abstract] [Full Text] [Related]
[Next] [New Search]
